Pei-Ken Hsu

Pei-Ken Hsu has a diverse and extensive work experience in the field of genetic engineering and molecular biology. They have held roles in various organizations, including Nutcracker Therapeutics, ArsenalBio, System1 Biosciences, Synthego Corporation, Northwestern University, Feinberg School of Medicine, Howard Hughes Medical Institute, UCSF, Columbia University, and National Taiwan University. Hsu's experience includes working as a Director, Principal Scientist, Senior Scientist, Scientist, Research Assistant Professor, Postdoctoral Associate, Postdoctoral Fellow, Graduate Student, and Teaching Assistant. They have expertise in areas such as CRISPR technology, gene engineering, stem cell technologies, Alzheimer's disease, sleep regulation, and histology. Throughout their career, Hsu has contributed to the development and advancement of various technologies and has played important roles in research projects and management.

Pei-Ken Hsu earned a Bachelor of Science (BS) degree in Zoology from National Taiwan University in 1999. Then, from 2003 to 2005, they pursued a Master of Science (MS) degree in Molecular and Cellular Biology at the same institution. From 2005 to 2012, they attended Columbia University, where they obtained a Doctor of Philosophy (PhD) degree in Cellular, Molecular Biology and Biophysics. Additionally, in the year 2000, Pei-Ken Hsu briefly studied Biology/Biological Sciences, General at The Johns Hopkins University.